EMAIL THIS PAGE TO A FRIEND

Eksperimental'naia i klinicheskaia farmakologiia

[Effects of silymarin and its combination with succinic acid on brain bioenergetics in rats with experimental inhibition of beta-oxidation of fatty acids].


PMID 17523453

Abstract

In the tests on rats with a model of encephalopathy caused by 4-pentenoic acid (inhibitor of the beta-oxidation of fatty acids), the hepatoprotective agent silymarin increases the respiratory activity in brain mitochondria, improves oxidative phosphorylation coupling and energization, and inhibits lipid peroxidation. Succinic acid (a regulator of bioenergetics) improves the damaged Krebs cycle metabolic pathways and produces an antioxidant effect. The combined use of silymarin and succinic demonstrated more expressed cerebroprotective action as compared to that of each agent administered separately.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

245925
4-Pentenoic acid, 97%
C5H8O2
W284300
4-Pentenoic acid, ≥98%, stabilized, FG
C5H8O2